Effect of metformin or gliclazide on lipid peroxidation and antioxidant levels in patients with diabetes mellitus

Turkish Journal of Medical Sciences

Volumn 38, Issue 6, 2008, Pages 545-548

  Memişoǧullari, Ramazan ^a   Türkeli, Mehmet ^b   Bakan, Ebubekir ^b   Akçay, Fatih ^b  

^a DUZCE UNIVERSITY   (Turkey)

^b ATATURK UNIVERSITY   (Turkey)

Author keywords

Antioxidant enzymes; Diabetes mellitus; Gliclazide; Malondialdehyde; Metformin

Indexed keywords

ALDEHYDES; CATALYSTS; ENZYMES; NUTRITION; OXIDATIVE STRESS; PROTEINS; SUGAR (SUCROSE); SYSTEM THEORY;

ANTIOXIDANT ENZYMES; DIABETES MELLITUS; GLICLAZIDE; MALONDIALDEHYDE; METFORMIN;

PLANTS (BOTANY);

CATALASE; GLICLAZIDE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLUTATHIONE TRANSFERASE; MALONALDEHYDE; METFORMIN;

ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC DIET; DIABETIC PATIENT; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; ERYTHROCYTE; EVALUATION; HUMAN; HUMAN CELL; LIPID PEROXIDATION; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; THERAPY EFFECT; TREATMENT OUTCOME; TREATMENT RESPONSE;

EID: 56849103892     PISSN: 13000144     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Taysi S, Kocer I, Memisogullari R, Kiziltunc A. Serum oxidant/antioxidant status in patients with Behçet's disease. Ann Clin Lab Sci 2002; 32: 377-82.
2. Memisogullari R, Taysi S, Bakan E, Capoglu I. Antioxidant status and lipid peroxidation in type II diabetes mellitus. Cell Biochem Funct 2003; 21: 291-6.
3. Memisogullari R, Bakan E. Levels of ceruloplasmin, transferrin, and lipid peroxidation in the serum of patients with type 2 diabetes mellitus. J Diabetes Complications 2004; 18: 193-7.
4. Memisogullari R, Gümüştekin K, Dane Ş, Akçay F. Effect of preinjury supplementation of selenium or vitamin E on lipid peroxidation and antioxidant enzymes in burn injury. Turk J Med Sci 2006; 36: 141-6.
5. Kimoto K, Suzuki K, Kizaki T, Hitomi Y, Ishida H, Katsuta H et al. Gliclazide protects pancreatic b-cells from damage by hydrogen peroxide. Biochem Bioph Res Co 2003; 303: 112-9.
6. Jennings PE, Belch JJ. Free radical scavenging activity of sulfonylureas: a clinical assessment of the effectiveness of gliclazide. Ter Arkh 2001; 73: 27-31.
7. Tessier D, Maheux P, Khalil A, Fulop T. Effects of gliclazide versus metformin on the clinical profile and lipid peroxidation markers in type 2 diabetes. Metabolism 1999; 48: 897-903.
8. Sliwinska A, Blasiak J, Kasznicki J, Drzewoski J. In vitro effect of gliclazide on DNA damage and repair in patients with type 2 diabetes mellitus (T2DM). Chem Biol Interact 2008; 173: 159-65.
9. Formoso G, De Filippis EA, Michetti N, Di Fulvio P, Pandolfi A, Bucciarelli T et al. Decreased in vivo oxidative stress and decreased platelet activation following metformin treatment in newly diagnosed type 2 diabetic subjects. Diabetes Metab Res Rev 2008; 24: 231-7.
10. Majithiya JB, Balaraman R. Metformin reduces blood pressure and restores endothelial function in aorta of streptozotocin-induced diabetic rats. Life Sci 2006; 78(22): 2615-24.
11. Iida KT, Kawakami Y, Suzuki M, Shimano H, Toyoshima H, Sone H et al. Effect of thiazolidinediones and metformin on LDL oxidation and aortic endothelium relaxation in diabetic GK rats. Am J Physiol Endocrinol Metab 2003; 284: E1125-E1130.
12. Bonnefont-Rousselot D. Antioxidant and anti-AGE therapeutics: evaluation and perspectives. J Soc Biol 2001; 195: 391-8.
13. Paglia DE, Valentina WN. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 1967; 70: 158-69.
14. Aebi H. Catalase. In: Bergmeyer HU, editor. Methods of Enzymatic Analysis. Weinheim: Verlag Chemie; 1974. pp. 673-8.
15. Panteghini M, Bais R, van Solinge WW. Methodology, Enzymes. In: Burtis CA, Ashwood ER, Bruns DE, editors. Tietz Textbook of Clinical Chemistry and Molecular Diagnostics. Philadelphia: WB Saunders; 2006. pp. 1990-2106.
16. Sen CK, Marin E, Kretzschmar M, Hänninen O. Skeletal muscle and liver glutathione homeostasis in response to training, exercise, and immobilization. J Appl Physiol 1992; 73: 1265-72.
17. Jain SK, McVie R, Duett J, Herbst JJ. Erythrocyte membrane lipid peroxidation and glycosylated hemoglobin in diabetes. Diabetes 1989; 38: 1539-43.
18. Vallejo S, Angulo J, Peiro C, Sanchez-Ferrer A, Cercas E, Llergo JL et al. Prevention of endothelial dysfunction in streptozotocin-induced diabetic rats by gliclazide treatment. J Diabetes Complications 2000; 14: 224-33.
19. Rahimi R, Nikfar S, Larijani B, Abdollahi M. A review on the role of antioxidants in the management of diabetes and its complications. Biomed Pharmacother 2005; 59: 365-73.
20. Khouri H, Collin F, Bonnefont-Rousselot D, Legrand A, Jore D, Gardès-Albert M. Radical-induced oxidation of metformin. Eur J Biochem 2004; 271: 4745-52.
21. Alper G, Irer S, Duman E, Çaģlayan O, Yi̇lmaz C. Effect of Ideprenyl and gliclazide on oxidant stress/antioxidant status and DNA damage in a diabetic rat model. Endocr Res 2005; 31: 199-212.
22. Pavlovic D, Kocic R, Kocic G, Jevtovic T, Radenkovic S, Mikic D et al. Effect of four-week metformin treatment on plasma and erythrocyte antioxidative defense enzymes in newly diagnosed obese patients with type 2 diabetes. Diabetes Obes Metab 2000; 2: 251-6.